Atlas Trials

Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults

Clinical trial NCT07276620 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07276620
Sponsor
Xiangya Hospital of Central South University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Atopic Dermatitis (AD)
Start date
2025-11-30
Primary completion
2028-04-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.